Market Research Reports

Microfluidic Device System Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

106pages
Published Date: 2014-05-14
 

Description


Microfluidics is an evolving scientific field with numerous analytical applications and commercial potential. Microfluidic devices have several applications in the field of medicine, cell biology research and protein crystallization. Thus, microfluidic technology is an important tool to reduce side effects and improve the efficacy of treatments. It has many applications in other areas such as drug screening, sugar testers, chemical micro reactor, microprocessor cooling and micro fuel cells. Rising demand for point of care testing, miniaturization of chip, and increasing demand for microfluidic devices in genomics and proteomics are the key growth drivers for the microfluidic device market. In addition, change in material mix would provide opportunity for new market entrants, which would further drive the growth of the microfluidic device market. 

On the other hand, strict regulatory requirements are a major concern for the industry. Safety, performance and consistent quality of medical devices are a necessity for public health. Thus, it leads to strict and complex regulations and standards for global affiliation of medical devices. In addition, major challenges faced by the microfluidic devices industry are the geometrical and surface chemistry issues during manufacturing of a device.

This report provides an in-depth analysis of estimation of the microfluidic device market for the period 2014-2019, considering 2013 as the base year for calculation. In addition, data pertaining to current market dynamics including market drivers, restraints, trends and strategic developments has been provided in the report. The microfluidic device market is categorized on the basis of material used for manufacturing microfluidic devices, industry, application and geography. Based on industry, the microfluidic device market comprises in-vitro diagnostics, pharmaceuticals and medical devices. The application market comprises point of care testing, analytical devices, pharmaceutical and life science research, clinical and veterinary diagnostics, drug delivery and environment and industry.

In the geographical analysis, the report identifies and analyses market size and forecast of North America, Europe, Asia and Rest of the World (Row). Some of the major players in the microfluidic device market are Roche Diagnostics, Abbott Laboratories, Siemens Healthcare, Agilent Technologies, Bio-Rad Laboratories, Fluidigm Corporation, Johnson & Johnson, Becton Dickinson and Company, and others. These key market players have been profiled on the basis of attributes such as company overview, recent developments, growth strategies, sustainability, and financial overview.

Table of Contents



Chapter 1 Preface 11
1.1 Report Description 11
1.2 Research Methodology 12
      1.2.1 Sources 12
              1.2.1.1 Secondary Research 12
              1.2.1.2 Primary Research 12
              1.2.1.3 Assumptions 13

Chapter 2 Executive Summary 14

Chapter 3 Industry Analysis 16
3.1 Introduction 16
3.2 Market Drivers and Opportunities 18
      3.2.1 Rising demand for point of care testing 18
      3.2.2 Miniaturization of chips, reduces cost of testing 19
      3.2.3 Increasing demand of microfluidic device in genomics and proteomics 19
      3.2.4 Change in material mix provides new opportunities for new players in the market 20
3.3 Restraints and Challenges 20
      3.3.1 Strict regulatory requirements 20
      3.3.2 Geometrical and surface chemistry issues are a challenge for microfluidics 21

Chapter 4 Market Trends 23
4.1 Rising number of collaborations and partnerships 23
4.2 Rising number of product innovations 24

Chapter 5 Porters Five Force Analysis 25
5.1 Bargaining power of buyers 25
5.2 Bargaining power of suppliers 25
5.3 Threat of new entrants 26
5.4 Threat of substitutes 26
5.5 Degree of competition 26

Chapter 6 Global Market Size and Forecast 27

Chapter 7 Segment Analysis – by Material 34
7.1 Glass 34
7.2 Polymer 36
7.3 Silicon 38

Chapter 8 Segment Analysis – by Industry 41
8.1 In-vitro diagnostics 41
8.2 Pharmaceuticals 43
8.3 Medical Devices 48

Chapter 9 Segment Analysis – by Application 52
9.1 Point of care testing 52
9.2 Pharmaceutical and life science research 54
9.3 Drug delivery 57
9.4 Analytical devices 59
9.5 Clinical and veterinary diagnostics 62
9.6 Environment and Industrial 64

Chapter 10 Regional Analysis 68
10.1 North America 68
10.2 Europe 70
10.3 Asia 73
10.4 Rest of the World 75

Chapter 11 Competitive Landscape 76

Chapter 12 Company Profiles 77
12.1 Roche Diagnostics 77
        12.1.1 Overview 77
        12.1.2 Products and segment 77
        12.1.3 Financial Performance 78
        12.1.4 Strategic Development 78
12.2 Abbott Laboratories 80
        12.2.1 Overview 80
        12.2.2 Products and segment 80
        12.2.3 Financial Performance 81
        12.2.4 Strategic Developments 82
12.3 Siemens Healthcare 83
        12.3.1 Overview 83
        12.3.2 Products and segment 83
        12.3.3 Financial Performance 84
        12.3.4 Strategic Development 84
12.4 Agilent Technologies Inc 85
        12.4.1 Overview 85
        12.4.2 Products and segment 85
        12.4.3 Financial Performance 86
12.5 Fluidigm Corporation 87
        12.5.1 Overview 87
        12.5.2 Products and segment 87
        12.5.3 Financial Performance 88
        12.5.4 Strategic Developments 88
12.6 Bio- Rad Laboratories 91
        12.6.1 Overview 91
        12.6.2 Products and segment 91
        12.6.3 Financial Performance 92
        12.6.4 Strategic Developments 92
12.7 Cepheid 94
        12.7.1 Overview 94
        12.7.2 Products and segment 94
        12.7.3 Financial Performance 94
        12.7.4 Strategic Developments 95
12.8 RainDance Technologies 97
        12.8.1 Overview 97
        12.8.2 Products and segment 97
        12.8.3 Financial Performance 97
        12.8.4 Strategic Development 97
12.9 Dolomite Centre 99
        12.9.1 Overview 99
        12.9.2 Products and segment 99
        12.9.3 Financial Performance 99
        12.9.4 Strategic Developments 99
12.10 Micronit Microfluidics 101
        12.10.1 Overview 101
        12.10.2 Products and segment 101
        12.10.3 Financial Performance 101
12.11 Johnson & Johnson 102
        12.11.1 Overview 102
        12.11.2 Product Segment 102
        12.11.3 Financial Performance 103
12.12 Becton, Dickinson and Company 104
        12.12.1 Overview 104
        12.12.2 Products and Segments 104
        12.12.3 Financial performance 105
        12.12.4 Strategic Developments 105

List of Figures 

FIG. 1 Applications of Microfluidics 16
FIG. 2 Functions of Microfluidics 17
FIG. 3 Aging population in major regions (% 2000-2050) 18
FIG. 4 Microfluidic Device Market: Porters Five Force Analysis 25
FIG. 5 Global microfluidic device market, by region 2013 (% share) 27
FIG. 6 Global microfluidic device market, by material 2013 (% share) 29
FIG. 7 Global microfluidic device market, by industry 2013 (% share) 30
FIG. 8 Global microfluidic device market, by application 2013 (% share) 32
FIG. 9 Glass microfluidic device market, by region 2013 (% share) 34
FIG. 10 Polymer microfluidic device market, by region 2013 (% share) 36
FIG. 11 Silicon microfluidic device market, by region 2013 (% share) 39
FIG. 12 In-vitro diagnostics industry in microfluidic device market, by region 2013 (% share) 41
FIG. 13 Pharmaceutical industry in microfluidic device market, by region 2013 (% share) 43
FIG. 14 Pharmaceutical industry in microfluidic device market, by product 2013 (% share) 45
FIG. 15 Chips for lab analytics in microfluidic device market, by product 2013 (% share) 47
FIG. 16 Medical device industry in microfluidic device market, by region 2013 (% share) 49
FIG. 17 Medical devices industry in microfluidic device market, by product 2013 (% share) 50
FIG. 18 Microfluidic device material used in point of care testing in 2010 (% share) 52
FIG. 19 Point of care testing in microfluidic device market, by region 2013 (% share) 53
FIG. 20 Microfluidic device material in pharmaceutical and life science research in 2010 (% share) 55
FIG. 21 Pharmaceutical and life science research in microfluidic device market, by region 2013 (% share) 55
FIG. 22 Microfluidic device material in drug delivery in 2010 (% share) 57
FIG. 23 Drug delivery in microfluidic device market, by region 2013 (% share) 58
FIG. 24 Microfluidic device material in analytical devices in 2010 (% share) 60
FIG. 25 Analytical Devices in microfluidic device market, by region 2013 (% share) 60
FIG. 26 Microfluidic device material used in clinical and veterinary diagnosis in 2010 (% share) 62
FIG. 27 Clinical and veterinary diagnosis in microfluidic device market, by region 2013 (% share) 63
FIG. 28 Microfluidic device material in environment and industrial application in 2010 (% share) 65
FIG. 29 Environment and industrial application in microfluidic device market, by region 2013 (% share) 65
FIG. 30 The North American microfluidic device market, by country 2013 (% share) 69
FIG. 31 The European microfluidic device market, by country 2013 (% share) 71
FIG. 32 The Asian microfluidic device market, by country 2013 (% share) 74
FIG. 33 Competitive landscape of global microfluidic device market 76
FIG. 34 Roche sales and net income 2011-2013 (USD Million) 78
FIG. 35 Abbott Laboratories net sales and net earnings 2011-2013 (USD Million) 81
FIG. 36 Siemens revenue and net income 2011-2013 (USD Million) 84
FIG. 37 Agilent Technologies revenue and net income 2011-2013 (USD Million) 86
FIG. 38 Fluidigm Corporation total revenue and net income 2011-2013 (USD Million) 88
FIG. 39 Bio-Rad Laboratories net sales and net income 2010-2012 (USD Million) 92
FIG. 40 Cepheid sales and net income 2011-2013 (USD Million) 95
FIG. 41 Johnson & Johnson sales and net earnings 2011-2013 (USD Million) 103
FIG. 42 Becton, Dickinson and Company revenue and net income 2011-2013 (USD Million) 105

List of Tables

TABLE 1 Market Snapshot: microfluidic device market (2013 & 2019) 14
TABLE 2 Drivers for microfluidic devices market: Impact analysis 18
TABLE 3 Restraints for microfluidic devices market: Impact analysis 20
TABLE 4 Major collaborations and partnerships by microfluidic device companies (2011-2013) 23
TABLE 5 Some of the products launched by various companies 24
TABLE 6 Global microfluidic devices market size, by region 2009-2012 (USD million) 28
TABLE 7 Global microfluidic devices market size, by region 2013-2019 (USD million) 28
TABLE 8 Global microfluidic devices market size, by material 2009-2012 (USD million) 29
TABLE 9 Global microfluidic devices market size, by material 2013-2019 (USD million) 30
TABLE 10 Global microfluidic devices market size, by industry 2009-2012 (USD million) 31
TABLE 11 Global microfluidic devices market size, by industry 2013-2019 (USD million) 31
TABLE 12 Global microfluidic devices market size, by application 2009-2012 (USD million) 32
TABLE 13 Global microfluidic devices market size, by application 2013-2019 (USD million) 33
TABLE 14 Glass microfluidic devices market size, by region 2009-2012 (USD million) 35
TABLE 15 Glass microfluidic devices market size, by region 2013-2019 (USD million) 35
TABLE 16 Polymer microfluidic devices market size, by region 2009-2012 (USD million) 37
TABLE 17 Polymer microfluidic devices market size, by region 2013-2019 (USD million) 38
TABLE 18 Silicon microfluidic devices market size, by region 2009-2012 (USD million) 39
TABLE 19 Silicon microfluidic devices market size, by region 2013-2019 (USD million) 40
TABLE 20 In-vitro diagnostic industry in microfluidic devices market size, by region 2009-2012 (USD million) 42
TABLE 21 In-vitro diagnostic industry in microfluidic devices market size, by region 2013-2019 (USD million) 42
TABLE 22 Pharmaceutical industry in microfluidic devices market size, by region 2009-2012 (USD million) 44
TABLE 23 Pharmaceutical industry in microfluidic devices market size, by region 2013-2019 (USD million) 45
TABLE 24 Pharmaceutical industry in microfluidic devices market size, by products 2009-2012 (USD million) 46
TABLE 25 Pharmaceutical industry in microfluidic devices market size, by products 2013-2019 (USD million) 46
TABLE 26 Chips for lab analytics in microfluidic devices market size, by products 2009-2012 (USD million) 47
TABLE 27 Chips for lab analytics in microfluidic devices market size, by products 2013-2019 (USD million) 48
TABLE 28 Medical devices industry in microfluidic devices market size, by region 2009-2012 (USD million) 49
TABLE 29 Medical devices industry in microfluidic devices market size, by region 2013-2019 (USD million) 50
TABLE 30 Medical devices industry in microfluidic devices market size, by products 2009-2012 (USD million) 51
TABLE 31 Medical devices industry in microfluidic devices market size, by products 2013-2019 (USD million) 51
TABLE 32 Point of care testing in microfluidic devices market size, by region 2009-2012 (USD million) 53
TABLE 33 Point of care testing in microfluidic devices market size, by region 2013-2019 (USD million) 54
TABLE 34 Pharmaceutical and life science research in microfluidic devices market size, by region 2009-2012 (USD million) 56
TABLE 35 Pharmaceutical and life science research in microfluidic devices market size, by region 2013-2019 (USD million) 56
TABLE 36 Drug delivery in microfluidic devices market size, by region 2009-2012 (USD million) 58
TABLE 37 Drug delivery in microfluidic devices market size, by region 2013-2019 (USD million) 59
TABLE 38 Analytical devices in microfluidic devices market size, by region 2009-2012 (USD million) 61
TABLE 39 Analytical devices in microfluidic devices market size, by region 2013-2019 (USD million) 61
TABLE 40 Clinical and veterinary diagnostics in microfluidic devices market size, by region 2009-2012 (USD million) 63
TABLE 41 Clinical and veterinary diagnostics in microfluidic devices market size, by region 2013-2019 (USD million) 64
TABLE 42 Environment and industrial application in microfluidic devices market size, by region 2009-2012 (USD million) 66
TABLE 43 Environment and industrial application in microfluidic devices market size, by region 2013-2019 (USD million) 66
TABLE 44 The North American microfluidic devices market size, by country 2009-2012 (USD million) 69
TABLE 45 The North American microfluidic devices market size, by country 2013-2019 (USD million) 70
TABLE 46 The European microfluidic devices market size, by country 2009-2012 (USD million) 71
TABLE 47 The European microfluidic devices market size, by country 2013-2019 (USD million) 72
TABLE 48 The Asian microfluidic devices market size, by country 2009-2012 (USD million) 74
TABLE 49 The Asian microfluidic devices market size, by country 2013-2019 (USD million) 75
TABLE 50 Roche Diagnostics major product categories 77
TABLE 51 Abbott Laboratories major product categories 80
TABLE 52 Siemens Healthcare major product categories 83
TABLE 53 Agilent Technologies major product categories 85
TABLE 54 Major Fluidigm Corporation products and its application 87
TABLE 55 Major Bio-Rad laboratories products and categories 91
TABLE 56 Major Cepheid products and categories 94
TABLE 57 Major RainDance Technologies products and its applications 97
TABLE 58 Major Dolomite Centre products and categories 99
TABLE 59 Major Micronit Microfluidics products and categories 101
TABLE 60 Major Johnson & Johnson segments and products 102
TABLE 61 Major Becton, Dickinson and Company segments and products 104

Enquiry Before Buying


Free Market Analysis


Microfluidics is an evolving scientific field with numerous analytical applications and commercial potential. Globally, the microfluidic device market is witnessing significant growth due to increasing R&D investment in pharmaceuticals, life science and rising point of care testing demand. New trends in healthcare, such as health care at home, supports point of care testing (POCT) as the most efficient and effective delivery of healthcare. Additionally, the microfluidic technique has evolved into a new classification of research areas, targeting integration of laboratory protocols into miniaturized devices called lab on chip. Microfluidic devices offer various advantages for genomics including improved test speed, reduced reagent consumption and efficacy. The global microfluidic device market was valued at USD 1,531.2 million in 2013. It is likely to grow at a CAGR of 22.8% during 2013 to 2019 to reach USD 5,246.4 million in 2019.

North America has the largest share in the global microfluidic device market. In-vitro diagnostics is the largest industry, and clinical and veterinary diagnostics is the largest application of microfluidic device market. In terms of growth, Asia is the fastest growing region, medical devices are the fastest growing industry and point of care testing is the fastest growing application of microfluidic devices.

The global microfluidic device market was valued at USD 1,531.2 million in 2013 and is expected to reach USD 5,246.4 million in 2019, growing at a CAGR of 22.8% for the period 2013-2019. 

North America was valued at USD 644.5 million in 2013 and is expected to reach USD 2,095.5 million in 2019, growing at a CAGR of 21.7% from 2013 to 2019.

In-vitro diagnostics microfluidic device market was valued at USD 949.6 million in 2013 and is expected to reach USD 3,317.4 million in 2019, growing at a CAGR of 23.2% from 2013 to 2019.
 

To get discount on this report, just click on the button below.

To receive brochure, please click on the button below.

Share This Market Study!  

Upcoming Report

Payment
Copyright @ Transparency Market Research